Independent Financial Group LLC Invests $602,000 in National Health Investors, Inc. $NHI

Independent Financial Group LLC acquired a new stake in shares of National Health Investors, Inc. (NYSE:NHI) during the 1st quarter, Holdings Channel reports. The fund acquired 7,443 shares of the real estate investment trust’s stock, valued at approximately $602,000.

A number of other large investors also recently modified their holdings of the company. International Assets Investment Management LLC bought a new position in National Health Investors in the 4th quarter worth $27,000. EverSource Wealth Advisors LLC lifted its position in shares of National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new position in shares of National Health Investors in the fourth quarter valued at about $33,000. GAMMA Investing LLC boosted its stake in shares of National Health Investors by 41.8% in the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 136 shares during the period. Finally, Key Capital Management INC bought a new position in shares of National Health Investors in the fourth quarter worth about $47,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Insider Activity at National Health Investors

In other news, Director Robert A. Mccabe, Jr. bought 890 shares of the stock in a transaction dated Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO D. Eric Mendelsohn bought 1,500 shares of the stock in a transaction dated Friday, June 5th. The shares were purchased at an average price of $68.84 per share, with a total value of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is owned by corporate insiders.

National Health Investors Price Performance

NYSE:NHI opened at $80.04 on Thursday. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $3.88 billion, a P/E ratio of 25.82, a P/E/G ratio of 3.64 and a beta of 0.51. National Health Investors, Inc. has a 12 month low of $67.94 and a 12 month high of $91.38. The business’s 50-day moving average is $74.80 and its 200 day moving average is $79.69.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.68 dividend on an annualized basis and a yield of 4.6%. National Health Investors’s payout ratio is presently 118.71%.

Wall Street Analysts Forecast Growth

NHI has been the topic of several recent analyst reports. Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Wells Fargo & Company dropped their price target on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research note on Monday, June 1st. Zacks Research lowered shares of National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Truist Financial reduced their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research report on Friday, June 12th. Finally, BMO Capital Markets lowered their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a report on Monday, June 15th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $83.86.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.